NASDAQ:ALPN
Alpine Immune Sciences, Inc.
- Stock
Last Close
64.96
17/05 20:00
Market Cap
4.46B
Beta: 1.26
Volume Today
4.29M
Avg: 76.25K
PE Ratio
−24.74
PFCF: −20.65
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -343K - | -537K 56.56% | -355.50K 33.80% | -320K 9.99% | -242K 24.38% | |||||||
average payables | 799.81K - | 961.47K 20.21% | 1.46M 51.59% | 1.06M 27.48% | 954.50K 9.70% | 1.63M 70.72% | 1.06M 34.80% | 1.97M 84.99% | 3.82M 94.23% | 3.94M 3.20% | ||
average receivables | 64K - | 182.50K 185.16% | 461.50K 152.88% | 537K 16.36% | 12.86M 2,293.95% | 13.02M 1.25% | 438K 96.63% | |||||
book value per share | -40.02 - | -6.91 82.74% | 35.64 616.07% | 14.31 59.84% | 12.18 14.94% | 3.22 73.56% | 1.61 50.14% | 2.98 85.90% | 4.75 59.00% | 5.37 13.08% | 6.56 22.22% | |
capex per share | -0.05 - | -0.00 96.72% | -0.08 4,364.68% | -0.03 65.89% | -0.09 230.33% | -0.04 60.47% | -0.04 25.12% | -0.04 13.89% | -0.00 87.97% | -0.01 166.05% | -0.01 20.96% | |
capex to depreciation | -0.57 - | -0.05 91.69% | -2.85 5,905.44% | -0.74 73.98% | -2.43 228.03% | -1.28 47.53% | -1.75 37.51% | -1.39 20.90% | -0.19 86.28% | -0.69 262.60% | 0.07 109.44% | |
capex to operating cash flow | 0.01 - | 0.00 96.76% | 0.01 3,349.19% | 0.00 58.76% | 0.04 775.98% | 0.02 50.74% | 0.02 33.34% | -0.03 214.77% | 0.01 129.03% | 0.01 21.68% | 0.01 34.54% | |
capex to revenue | -0.34 - | -0.70 107.40% | -0.47 32.80% | -0.09 81.79% | -0.01 94.14% | -0.01 172.26% | -0.01 39.64% | |||||
cash per share | 0.48 - | 12.19 2,433.18% | 37.24 205.48% | 15.76 57.69% | 12.53 20.47% | 3.78 69.87% | 2.21 41.56% | 5.07 129.69% | 6.37 25.66% | 7.11 11.57% | 6.55 7.87% | |
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | 26.99 - | 122.70 354.62% | 143.90 17.28% | 15.17 89.46% | 394.27 2,498.87% | 8.61 97.82% | 1.04 87.97% | |||||
debt to assets | 3.71 - | 0.06 - | 0.08 29.67% | 0.30 294.76% | 0.16 48.13% | 0.08 51.09% | 0.05 35.33% | 0.03 47.38% | ||||
debt to equity | -0.17 - | 0.06 - | 0.09 47.76% | 0.55 488.74% | 0.36 34.49% | 0.16 55.35% | 0.08 51.18% | 0.03 61.86% | ||||
dividend yield | ||||||||||||
earnings yield | -0.12 - | -0.11 7.17% | -0.31 184.83% | -0.91 188.20% | -0.11 88.18% | -0.72 567.75% | -0.60 15.72% | -0.11 82.35% | -0.14 33.97% | -0.24 64.78% | -0.03 85.63% | |
enterprise value | 150.38M - | 108.32M 27.97% | 47.54M 56.11% | 10.50M 77.92% | 69.63M 563.19% | 44.46M 36.15% | 70.73M 59.10% | 250.05M 253.53% | 304.58M 21.80% | 246.59M 19.04% | 919.00M 272.68% | |
enterprise value over ebitda | -9.99 - | -7.68 23.15% | -2.08 72.97% | -0.33 84.15% | -4.91 1,390.88% | -1.26 74.35% | -1.70 35.40% | -9.20 440.14% | -6.14 33.28% | -4.49 26.92% | -20.77 362.84% | |
ev to operating cash flow | -10.52 - | -7.50 28.74% | -2.48 66.99% | -0.40 83.85% | -4.20 950.85% | -1.56 62.76% | -2.00 27.90% | 8.31 515.36% | -19.97 340.32% | -5.64 71.78% | -11.63 106.37% | |
ev to sales | 40.22 - | 63.06 56.77% | 40.65 35.54% | 26.79 34.10% | 12.99 51.50% | 8.20 36.87% | 15.61 90.30% | |||||
free cash flow per share | -6.32 - | -6.34 0.24% | -8.28 30.67% | -6.81 17.77% | -2.65 61.11% | -2.09 21.14% | -1.97 5.63% | 1.41 171.37% | -0.60 142.90% | -1.32 119.01% | -1.59 20.37% | |
free cash flow yield | -0.11 - | -0.11 0.24% | -0.27 151.89% | -0.76 184.12% | -0.24 68.89% | -0.57 140.00% | -0.51 9.56% | 0.11 121.75% | -0.04 139.03% | -0.18 312.70% | -0.08 53.58% | |
graham net net | -41.35 - | -7.23 82.52% | 35.36 589.29% | 14.08 60.18% | 11.58 17.79% | 3.05 73.68% | 0.88 71.27% | 1.14 30.24% | 1.81 58.83% | 3.91 115.94% | 5.71 46.00% | |
graham number | 79.96 - | 32.00 59.98% | 88.37 176.14% | 51.15 42.12% | 18.14 64.54% | 13.81 23.83% | 9.15 33.78% | 9.49 3.75% | 14.52 53.02% | 14.44 0.56% | 9.75 32.52% | |
income quality | 0.88 - | 0.96 8.89% | 0.84 12.40% | 0.83 0.85% | 2.13 155.12% | 0.78 63.42% | 0.84 8.44% | -1.08 227.49% | 0.30 128.14% | 0.76 150.04% | 2.46 224.10% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0.02 Infinity% | 0 100% | 0 | 0 | -0.04 Infinity% | 0 100% | 0 | |
interest coverage | -16.41 - | -17.14 4.47% | -98.51 - | -118.59 20.38% | -128.92 8.71% | -37.10 71.23% | -61.10 64.71% | -122.16 99.92% | -451.53 269.63% | |||
interest debt per share | 7.13 - | 0.37 94.81% | 0.80 - | 0.33 59.19% | 0.91 178.49% | 1.12 23.42% | 0.80 28.50% | 0.44 45.22% | 0.20 54.45% | |||
inventory turnover | ||||||||||||
invested capital | -0.17 - | 0.06 - | 0.09 47.76% | 0.55 488.74% | 0.36 34.49% | 0.16 55.35% | 0.08 51.18% | 0.03 61.86% | ||||
market cap | 136.14M - | 136.14M 0% | 72.53M 46.72% | 34.70M 52.16% | 72.59M 109.19% | 50.97M 29.79% | 70.50M 38.32% | 262.41M 272.23% | 352.85M 34.47% | 245.75M 30.35% | 953.01M 287.80% | |
net current asset value | -93.62M - | -15.85M 83.07% | 83.27M 625.22% | 55.16M 33.75% | 76.24M 38.21% | 43.26M 43.26% | 17.68M 59.13% | 25.17M 42.33% | 57.02M 126.53% | 133.73M 134.54% | 288.05M 115.40% | |
net debt to ebitda | -0.95 - | 1.97 308.28% | 1.09 44.65% | 0.76 30.49% | 0.21 72.45% | 0.18 11.87% | -0.01 103.05% | 0.45 8,205.63% | 0.97 113.94% | -0.02 101.58% | 0.77 5,098.20% | |
net income per share | -7.10 - | -6.59 7.17% | -9.74 47.76% | -8.12 16.59% | -1.20 85.22% | -2.63 119.40% | -2.32 12.06% | -1.34 42.09% | -1.98 47.26% | -1.73 12.56% | -0.64 62.74% | |
operating cash flow per share | -6.27 - | -6.33 1.08% | -8.20 29.44% | -6.78 17.30% | -2.56 62.29% | -2.05 19.75% | -1.93 6.17% | 1.44 175.03% | -0.60 141.43% | -1.31 118.65% | -1.58 20.76% | |
payables turnover | ||||||||||||
receivables turnover | 13.52 - | 2.97 78.00% | 2.54 14.73% | 24.06 848.54% | 0.93 96.15% | 42.40 4,480.39% | 352.55 731.42% | |||||
research and ddevelopement to revenue | 6.14 - | 41.09 569.40% | 20.60 49.86% | 2.91 85.86% | 2.51 13.96% | 2.34 6.76% | 1.37 41.19% | |||||
return on tangible assets | -3.92 - | -0.53 86.55% | -0.26 50.73% | -0.51 95.71% | -0.09 81.71% | -0.66 615.67% | -0.79 18.25% | -0.19 75.34% | -0.19 2.66% | -0.20 6.75% | -0.08 57.95% | |
revenue per share | 0.27 - | 0.05 80.94% | 0.09 86.19% | 0.45 372.93% | 0.92 105.29% | 0.90 2.28% | 1.18 30.96% | |||||
roe | 0.18 - | 0.95 437.95% | -0.27 128.63% | -0.57 107.67% | -0.10 82.62% | -0.82 729.69% | -1.44 76.36% | -0.45 68.85% | -0.42 7.38% | -0.32 22.67% | -0.10 69.52% | |
roic | 0.21 - | 0.99 364.89% | -0.27 127.64% | -0.57 109.48% | -0.17 69.64% | -0.77 341.41% | -0.77 0.76% | -0.30 61.78% | -0.33 10.65% | -0.30 9.42% | -0.13 56.92% | |
sales general and administrative to revenue | 3.51 - | 11.86 237.74% | 5.44 54.13% | 1.17 78.54% | 0.62 46.80% | 0.60 3.77% | 0.38 36.85% | |||||
shareholders equity per share | -40.02 - | -6.91 82.74% | 35.64 616.07% | 14.31 59.84% | 12.18 14.94% | 3.22 73.56% | 1.61 50.14% | 2.98 85.90% | 4.75 59.00% | 5.37 13.08% | 6.56 22.22% | |
stock based compensation to revenue | 0.48 - | 3.28 576.53% | 1.75 46.64% | 0.44 74.62% | 0.27 39.98% | 0.32 20.56% | 0.18 43.74% | |||||
tangible asset value | -91.29M - | -15.75M 82.74% | 83.49M 630.02% | 55.44M 33.60% | 77.46M 39.74% | 44.59M 42.44% | 29.47M 33.90% | 62.16M 110.89% | 131.67M 111.83% | 179.42M 36.26% | 337.87M 88.31% | |
tangible book value per share | -40.02 - | -6.91 82.74% | 35.64 616.07% | 14.31 59.84% | 11.95 16.50% | 3.22 73.06% | 1.61 50.14% | 2.98 85.90% | 4.75 59.00% | 5.37 13.08% | 6.76 25.93% | |
working capital | -2.21M - | 26.03M 1,278.33% | 83.27M 219.93% | 55.16M 33.75% | 80.65M 46.21% | 45.42M 43.69% | 33.62M 25.97% | 65.93M 96.11% | 122.23M 85.39% | 183.00M 49.71% | 288.05M 57.41% |
All numbers in USD (except ratios and percentages)